Categories: Technology

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard.

 | Source: Semilux International Ltd.

Taipei, Taiwan, Jan. 08, 2026 (GLOBE NEWSWIRE) — Semilux International Ltd. (the “Company”) received a letter (the “MVLS Deficiency Notice”) from the listing qualifications department staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that that from November 13, 2025 to December 30, 2025, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”).

The MVLS Deficiency Notice has no immediate effect on the listing of the Company’s ordinary shares, and the Company’s common stock continues to trade on the Nasdaq Global Market under the symbol “SELX.”

In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has 180 calendar days from the date of the MVLS Deficiency Notice, or through June 29, 2026 (the “Compliance Date”), to regain compliance with respect to the MVLS Requirement. The MVLS Deficiency Notice states that if the Company’s MVLS closed at $35 million or more for a minimum of ten consecutive business days during the compliance period ending on the Compliance Date, the Staff will provide written confirmation of compliance. 

If the Company does not regain compliance by the Compliance Date, Nasdaq will provide written notice to the Company that its securities are subject to delisting. At that time, the Company may appeal any such delisting determination. However, there can be no assurance that, if the Company receives a delisting notice from the Staff and appeals the delisting determination, such appeal would be successful.

The Company intends to actively monitor the Company’s MVLS between now and the Compliance Date and will take all reasonable measures available to the Company to regain compliance with the MVLS Requirement. While the Company is exercising diligent efforts to maintain the listing of its ordinary shares on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with the applicable continued listing standards set forth in the Nasdaq Listing Rules.

Investor Relations Contact:

Email: IR@semilux.com

GlobeNews Wire

Recent Posts

Press Release: Sanofis Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease

Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease Recommendation…

4 hours ago

Immunocore announces R&D leadership evolution

Immunocore announces R&D leadership evolution Dr. David Berman will depart the Company Dr. Mohammed Dar,…

4 hours ago

Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit

TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT…

4 hours ago

Monika Alcobev Partners with Renowned Designer Gaurav Gupta to Celebrate the Launch of his Flagship Store at DLF Emporio

~ 1800 Tequila Serves as the Exclusive Liquor Partner ~NEW DELHI, Jan. 29, 2026 /PRNewswire/…

5 hours ago

Integrow to Acquire Cloud Consulting Inc., Boosting Cloud Solutions

Deal Boosts Integrow's Capabilities in Cloud Consulting, Professional Services, and Customer TransformationATLANTA, Jan. 30, 2026 /PRNewswire/…

5 hours ago

INDIA’S MOST AWAITED ENTERPRISE TECH CONCLAVE IS BACK

Announcing ETCIO Annual Conclave 2026BAMBOLIM, India, Jan. 30, 2026 /PRNewswire/ -- The Economic Times CIO is…

5 hours ago